{"podcast":{"title":"Few & Far Between: How Biotech Gets Built","slug":"few-far-between-how-biotech-gets-built-4067896","podcast_index_feed_id":4067896,"rss_url":"https://feeds.castos.com/kd1o1","website_url":"https://biorasi.com/few-far-between-podcast/","image_url":"https://episodes.castos.com/6026d270a471b8-76273800/images/podcast/covers/c1a-7krkv-5zqr8dopfxo9-ndltai.jpg","author":"Adam Gottlieb","episode_count":35,"summary":"Welcome to Few & Far Between! Melissa Alesse, President of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.","last_synced_at":null,"page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896"},"episode":{"title":"Episode 49: Eileen Faucher, Principal and Founder, Brass Tacks Health","slug":"episode-49-eileen-faucher-principal-and-founder-brass-tacks-health","published_at":"2025-02-27T10:13:00+00:00","page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-49-eileen-faucher-principal-and-founder-brass-tacks-health","show_page_url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896","url":"https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-49-eileen-faucher-principal-and-founder-brass-tacks-health","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.castos.com/6026d270a471b8-76273800/1982985/c1e-z949nbmqjndhn7wog-34nwqgn0hx42-fmrbpb.mp3","summary":"Today on the Biorasi Few & Far Between podcast: What if you could read a story before its official release? Competitive intelligence gives you early access to information on emerging trends in clinical trials. On today's episode, host Chris O'Brien welcomes Eileen Faucher. Eileen is the Principal and Founder of Brass Tacks Health, a company that provides insights that biotechs need to drive clinically-meaningful therapies. Listen in to get the ROI on competitive intelligence, concise communications, and helping patients find relevant clinical trials. Thanks for listening!","meta_description":"Today on the Biorasi Few & Far Between podcast: What if you could read a story before its official release? Competitive intelligence gives you early acces…","key_points":[],"chapters":[],"topics":[],"duration_seconds":2137,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/episode-49-eileen-faucher-principal-and-founder-brass-tacks-health/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-49-eileen-faucher-principal-and-founder-brass-tacks-health.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}